The Effect of Vitamin D Supplementation on Glycemic Control in Type 2 Diabetes Patients: A Systematic Review and Meta-Analysis
Open accessThe DOI matches its Crossref record; 45 of the 50 references it cites were found in a registry or an index.
Abstract
Observational studies have indicated an inverse association between vitamin D levels and the risk of diabetes, yet evidence from population interventions remains inconsistent. PubMed, EMBASE, Cochrane Library and ClinicalTrials.gov were searched up to September 2017. Data from studies regarding serum 25(OH)D, fasting blood glucose (FBG), hemoglobin A1c (HbA1c), fasting insulin and homeostasis model assessment of insulin resistance (HOMA-IR) were pooled. Twenty studies (n = 2703) were included in the meta-analysis. Vitamin D supplementation resulted in a significant improvement in serum 25(OH)D levels (weighted mean difference (WMD) = 33.98; 95%CI: 24.60–43.37) and HOMA-IR (standardized mean difference (SMD) = −0.57; 95%CI: −1.09~−0.04), but not in other outcomes. However, preferred changes were observed in subgroups as follows: short-term (WMDFBG = −8.44; 95%CI: −12.72~−4.15), high dose (WMDFBG = −8.70; 95%CI: −12.96~−4.44), non-obese (SMDFasting insulin = −1.80; 95%CI: −2.66~−0.95), Middle Easterners (WMDFBG = −10.43; 95%CI: −14.80~−6.06), baseline vitamin D deficient individuals (WMDFBG = −5.77; 95%CI: −10.48~−1.05) and well-controlled HbA1c individuals (WMDFBG = −4.09; 95%CI: −15.44~7.27). Vitamin D supplementation was shown to increase serum 25(OH)D and reduce insulin resistance effectively. This effect was especially prominent when vitamin D was given in large doses and for a short period of time, and to patients who were non-obese, Middle Eastern, vitamin D deficient, or with optimal glycemic control at baseline.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The main limitation of these studies is the wide variation in methodologies including differences in the type, formulation, concentration, and duration of exposure to probiotics.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1706]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Several RCTs and systematic reviews/meta-analyses have noted a positive effect of probiotics on glucose, A1C, lipids, and BP.1705–1714”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1706]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305 · cited 1×
“The strength of the evidence was categorized as high, moderate, low or very low [19].”
BackgroundVos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Self-citationHolick, M. F., Binkley, N. C., Bischoff-Ferrari, H. A., Gordon, C. M., Hanley, D. A., Heaney, R. P., Murad, M. H., & Weaver, C. M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0385 · Cited by 10,538
Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. The Cochrane Collaboration
Higgins, J. P. T., Green, S. R., & Higgins, J. P. T. (2008) · Cited by 7,171
The Role of Vitamin D and Calcium in Type 2 Diabetes. A Systematic Review and Meta-Analysis
Pittas, A. G., Lau, J., Hu, F. B., & Dawson-Hughes, B. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0298 · Cited by 2,001
Vitamin D and type 2 diabetes: a systematic review
Mitri, J., Muraru, M. D., & Pittas, A. G. (2011) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2011.118 · Cited by 570
Research works printed but not linked: 1
- Li, 2016, Effects of Vitamin D Supplementation on Glycaemic Control, Insulin Resistance and β Cell Function in Type 2 Diabetes Mellitus: A Meta-analysis, Chin. J. Evid.-Based Med., 16, 1080
Cited by
Items 201–265 of 265
Nyulas, K.-I., Simon-Szabó, Z., Preg, Z., Pál, S., Sharma, A., Pál, T., Germán-Salló, M., & Nemes-Nagy, E. (2022) · Journal of Interdisciplinary Medicine · doi:10.2478/jim-2022-0021 · Cited by 1
Mi, N., Liu, M., Meng, C., & Fu, F. (2023) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/171451 · Cited by 3
Tyagi, S., & Mani, S. (2023) · Cardiovascular & Hematological Agents in Medicinal Chemistry · doi:10.2174/0118715257261643231018102928 · Cited by 2
Ji, L., Li, S., Yuan, T., Li, S., Shu, R., & Yang, H. (2025) · Lipids · doi:10.1002/lipd.12429 · Cited by 1
Molani‐Gol, R., Rafraf, M., Jafarabadi, M. A., Aftabi‐Yousefabad, S., & Shanehbandi, D. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16497 · Cited by 1
“66 It is proposed that obese people's response to vitamin D supplementation is approximately 30% lower compared to non-obese individuals, and vitamin D replacement therapy should be tailored based on body size to reach the desired serum 25(OH)D levels.”
Коморбідність за цукрового діабету 1-го та 2-го типу. Вітамін D у системі моніторингу
Гончарова, О. А. (2021) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.17.1.2021.226426 · Cited by 1
Hong, J. H. (2021) · Journal of Korean Diabetes · doi:10.4093/jkd.2021.22.1.6 · Cited by 1
Prevention and Treatment of Diabetic Nephropathy with Vitamin D
Petrović, M., Petrović, S., & Obrenčević, K. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.106717 · Cited by 1
Tyagi, S., & Mani, S. (2023) · Research Square · doi:10.21203/rs.3.rs-3539016/v1 · Cited by 1
Muschitz, C., Kautzky‐Willer, A., Winhofer, Y., Rauner, M., Haschka, J., Cejka, D., Wakolbinger, R., & Pietschmann, P. (2023) · Wiener klinische Wochenschrift · doi:10.1007/s00508-022-02118-8 · Cited by 4
Vitamin D in insulin sensitivity and obesity: Fact or fiction?
Pramono, A. (2020) · Research Publications (Maastricht University) · doi:10.26481/dis.20200828ap · Cited by 2
Salarinia, M., Azizi, M., Tahmasebi, W., & Khalvandi, H. (2021) · Research Square · doi:10.21203/rs.3.rs-178971/v1
Vitamin D in health and disease
Soeters, P. B., & de Leeuw, P. W. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820205-0.00019-0
The role of vitamin D in the development of cardiac arrhythmias in locomotive drivers
Nv, O., Starokozheva, A. Y., Zhidkova, E. А., & Гуревич, К. Г. (2021) · Russian Journal of Occupational Health and Industrial Ecology · doi:10.31089/1026-9428-2021-61-3-202-207 · Cited by 1
Elnaggar, Y., El‐Demerdash, E., Tolba, M. F., & Halawa, M. R. (2021) · Archives of Pharmaceutical Sciences Ain Shams University · doi:10.21608/aps.2021.58439.1051
Insulin Resistance in Chronic Kidney Disease: Is There a Distinct Role of Vitamin D?
Attea, H. A., El-Hamid, A. E.-D. A., Keshawy, M. M., & Khedr, M. A. (2021) · Suez Canal University Medical Journal · doi:10.21608/scumj.2021.192460
ANALYSIS OF VITAMIN D WITH INTRACTABLE DISEASES- A REVIEW.
Rumao, C., Puranik, C., Garg, D., & Deshwal, R. (2021) · International Journal of Medical and Biomedical Studies · doi:10.32553/ijmbs.v5i9.2219
Vitamin-D Deficiency among Patients with Diabetes Mellitus in Northern Borders Area of Saudi Arabia
Alotaibi, N. (2021) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs211592733
Rašević, O., Mulić, M., & Vuković, M. (2021) · Биомедицинска истраживања · doi:10.5937/bii2101099l
“RAAS is the largest regulator of blood pressure in the body.”
BackgroundInfluentialAlschuler, L. N., Chiasson, A. M., Brooks, A., Mk, C., & Marshall, K. M. (2021) · Journal of Family Medicine · doi:10.26420/jfammed.2021.1273
Bloomgarden, Z. T. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12865
A SUPLEMENTAÇÃO ASSOCIADA À REMISSÃO DO DIABETES MELLITUS TIPO 2
Neto, A. R., Algayer, G., Mattos, C. P., Orlando, L. M., Silva, T. F., Carvalho, A. L. P., de Souza, J. F., Cabral, D. S., Correia, I. P., Pereira, L. Q. F., et al. (2022) · doi:10.22533/at.ed.6722222082
CLASSIFICAÇÃO DE RISCO EM PACIENTES PEDIÁTRICOS NOS SERVIÇOS DE EMERGÊNCIA: ESTUDO BIBLIOMÉTRICO
da Silva, A., & Busnello, G. F. (2022) · doi:10.22533/at.ed.6722222084
HEMORRAGIA PÓS-PARTO: UM ESTUDO DE 2016 A 2021 NO ESTADO DE SÃO PAULO
Dietrich, G. M., Elias, F. R., Ramalho, C. P. L., Balseiro, L. M., Balseiro, E. M., & Silva, A. G. E. (2022) · doi:10.22533/at.ed.67222220815
DOR FANTASMA DE MEMBRO AMPUTADO E DOR NEUROGÊNICA DO PLEXO BRAQUIAL: RELATO DE CASO
Pereira, F. C., de Oliveira, L. N. A., Martins, R. Z., Passos, E. T., Fiúza, E. C. S., & de Menezes, I. L. (2022) · doi:10.22533/at.ed.6722222086
Santos, M. D. O., Moreira, A. L. E., Neto, B. R. D. S., da Silva, P. A. N., Ito, C. R. M., Wastowski, I. J., Carneiro, L. C., & Avelino, M. A. G. (2022) · doi:10.22533/at.ed.67222220810
ENDEREÇAMENTO NO CONTEXTO DE HIV/AIDS: UMA ABORDAGEM CRÍTICOREFLEXIVA
Pereira, T. A., & Dalmaso, A. C. (2022) · doi:10.22533/at.ed.6722222087
COMUNICAÇÃO DE MÁS NOTÍCIAS EM MEIO A PANDEMIA POR COVID-19: UMA ANÁLISE BIOÉTICA
Oliveira, B. T., Melo, M. H. D. S., & Gomes, R. R. (2022) · doi:10.22533/at.ed.6722222085
Julio, H. F., de Morais, V. G., Humberto, J. V., dos Santos, G. N. D. M., Ribeiro, W. J., Oliveira, S. M., Machado, R. A. A., Maranhão, M. G. M., de Jesus, R. C., Balena, G. Z., et al. (2022) · doi:10.22533/at.ed.6722222081
MECANISMOS DE DOR NA OSTEOARTRITE DE JOELHO
Felimberti, G., Bertol, C. D., Staudt, T., Tietze, A. P., da Rosa, K., Cardoso, L., & Spassim, M. R. (2022) · doi:10.22533/at.ed.67222220812
de Moraes, M. G. T., Souza, G. J. M., Souza, A. L. M., Souza, G. C. M., Neto, L. E. S., Valente, R. R., de Melo, J. J. L., Reis, D. M. M., Reis, A. P. M., Marinho, V. M. M., et al. (2022) · doi:10.22533/at.ed.67222220819
Klebsiella pneumoniae carbapenemase: UMA REVISÃO INTEGRATIVA
Gomes, M. A., Sousa, A. C. G. G., de Sousa, D. D. K. G. G., Pedroso, E. M., do Carmo, F. V., do Carmo, G. V., Machado, J. M. X., Macedo, L. E., Roncolato, M. C. D. S., de Santana, P. W. B., et al. (2022) · doi:10.22533/at.ed.67222220811
Muniz, O. X., Borges, H. F. D. S., de Freitas, A. G., Costa, A. B., Pereira, J. S., Dias, N. D. A., Praia, R. D. S., Ferreira, Y. M. C., Ferreira, H. A., Negreiros, L. S., et al. (2022) · doi:10.22533/at.ed.67222220814 · Cited by 3
SARCOPENIA E DOENÇA RENAL CRÔNICA: CONDIÇÕES ASSOCIATIVAS
Lima, L. Z. M., Silva, G. V. D. S., Gheller, E., Machado, A. R., Bizuti, M. R., de Cristo, D., Puhle, J. G., & Silva, D. T. D. R. E. (2022) · doi:10.22533/at.ed.67222220816
Streptococcus pneumoniae COMO CAUSADOR DE INFECÇÃO HOSPITALAR
Oliveira, R. A., Paiva, F. B., Lago, L. M. F. C., Inácio, M. M. B., Gomes, M. A., & Rodrigues, K. R. B. (2022) · doi:10.22533/at.ed.67222220818
Reyes, V. B., Noro, A., de Cezaro, P., Fernandes, A. P. W., Garcia, Y. E., Toss, L., Pires, I. D. S., Henriques, A. M. A., da Silva, F. G., Lunardi, L. S., et al. (2022) · doi:10.22533/at.ed.67222220817
Alam, M. S., Kalam, S. T., Saha, R., & Kamrul-Hasan, A. B. M. (2023) · Bangladesh Journal of Endocrinology and Metabolism · doi:10.4103/bjem.bjem_18_22
Vitamin D Status Study in Premenopausal Type 2 Diabetic Patients
曹, 卓. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.1351085
Empfehlungen zur Ernährung von Personen mit Typ-2-Diabetes mellitus
Skurk, T., Bosy‐Westphal, A., Grünerbel, A., Kabisch, S., Keuthage, W., Kronsbein, P., Müssig, K., Nussbaumer, H., Pfeiffer, A. F. H., Simon, M., et al. (2024) · Die Diabetologie · doi:10.1007/s11428-024-01174-0
Vitamin D therapy's preventive effect in type 2 diabetes mellitus
رضا, ش. ن. (2024) · journal of the college of basic education · doi:10.35950/cbej.v29i122.11166
Wang, G., Feng, S., Xu, J., Wei, X., & Yang, G. (2024) · Nutrients · doi:10.3390/nu16131979 · Cited by 1
A Quest for Potential Role of Vitamin D in Type II Diabetes Mellitus Induced Diabetic Kidney Disease
Obaid, A. A., Farrash, W. F., Mujalli, A., & Singh, S. K. (2024) · Current Pharmaceutical Design · doi:10.2174/0113816128296168240614071821
Yenni, Y., Wratsangka, R., Herwana, E., Kalumpiu, J. V., & Liman, P. B. (2024) · Rwanda medical journal · doi:10.4314/rmj.v81i2.5
22. Fatores Nutricionais no Diabetes Mellitus
Zuccolotto, D. C. C., & Sartorelli, D. S. (2024) · Editora FIOCRUZ eBooks · doi:10.7476/9786557081891.0025
Ilkay, H. O., & Samur, G. (2024) · Topics in Clinical Nutrition · doi:10.1097/tin.0000000000000330
“50,51 In a study of Brazilian adults with T2DM, glycemic control determined by HbA 1C (”
Chijioke‐Agu, O. E., & Emelike, C. U. (2025) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2025.100205
Low Vitamin D Status Attenuates Hypolipidemic and Pleiotropic Effects of Atorvastatin in Women
Krysiak, R. G., Kowalcze, K. E., Szkróbka, W., & Okopień, B. (2025) · Nutrients · doi:10.3390/nu17101674
“Moreover, vitamin D supplementation was reported to improve insulin sensitivity, fasting glucose, glycated hemoglobin (HbA 1c ), and plasma lipids [27,28].”
Hu, Y., Shao, L.-N., Zheng, J., Zhang, X., Song, Y., & Xing, Y.-B. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i6.105558 · Cited by 1
Vitamin D3 therapy and clinical outcome in recurrent pregnancy loss patients
Ramzan, K., Ramzan, A., Dar, A., dar, B. M. U. D., & Nisar, I. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13657-3.00006-4
Molani‐Gol, R., Rafraf, M., Jafarabadi, M. A., & Aftabi‐Yousefabad, S. (2025) · Nutrition and Diabetes · doi:10.1038/s41387-025-00402-w · Cited by 1
“Future research should focus on long-term clinical trials or higher doses of vitamin D to clarify these relationships and determine the effects of vitamin D supplements in both genders of populations with prediabetes.”
Gong, S., & Chen, L. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1677686
“The absence of significant glycemic benefit, particularly with respect to HbA1c reduction, mirrors findings from select prior meta-analyses (29, 30), though it diverges from others that have reported marginal yet statistically significant effects (31, 32).”
Chen, X.-Y., Zhang, Y., Wang, X.-X., Hao, L.-Y., Xue, M., & Xiao, W. (2026) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-026-02101-7
Self-citationVitamin D and Diabetes in Pakistan: A Comprehensive Review of Existing Literature
Afzal, N., Mahmood, A., Majid, H., Jafri, L., & Khan, A. H. H. (2026) · Cureus · doi:10.7759/cureus.106923
Bucheeri, S., Mubarak, A. F., Aldoseri, J. Y., Redha, A., Kumar, N., & Mohamed, S. F. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15083158
Ernährungsempfehlungen für Menschen mit Diabetes (Update 2026)
Klammer, C., Schindler, K., Bugl, R., Plazek, D., Vötter, M., Kirchner, T., Martino, C., Klammer-Martin, J., Huber, J., Krzizek, E.-C., et al. (2026) · Wiener klinische Wochenschrift · doi:10.1007/s00508-025-02676-7
Taiwanese consensus statement on the use of diabetes‐specific formula: Scientific evidence
Ch, C., Peng, H.-Y., Lee, C., Wang, C., Ko, Y., Chen, W., Hsu, P.-H., Huang, C., Yang, Y., Yeh, K.-M., et al. (2026) · Journal of Diabetes Investigation · doi:10.1111/jdi.70329
“Systematic reviews and meta-analyses have suggested that vitamin D supplementation (20 IU daily or up to a maximum single dose of 300,000 IU) can mitigate insulin resistance in patients with T2D who have vitamin D de fi ciency 59 .”
Considerations for Dietary Supplements after GLP-1RA Treatment: A Narrative Review
Johnson, B. V. B. (2026) · Journal of Nutrition · doi:10.1016/j.tjnut.2026.101695
Associations between PFAS exposure and 25-hydroxyvitamin D levels among Hispanic children
Mohsin, R., Gerona, R. R. L., Gallo, S., Jones, M. T., Krall, J. R., McKay, A. J., Espina, V. A., Sanchez, V. G., Tomer, D., Mehlenbeck, R., et al. (2026) · Environmental Research · doi:10.1016/j.envres.2026.125495
Tsai, Y., Lin, Y.-C., Tseng, K.-T., Chang, J., Jim, W.-T., Peng, C.-C., & Chang, H. (2026) · Nutrients · doi:10.3390/nu18182994
“Although some clinical studies have linked vitamin D deficiency to pancreatic β -cell dysfunction and diabetes risk [49,54], meta-analyses have reported inconsistent effects on glucose metabolism [55,56].”
Expanding non-calcaemic roles of vitamin D in therapeutics and their mechanisms
Kumar, S., GHOSH, A., Haque, I., & Tayal, V. (2026) · The National Medical Journal of India · doi:10.25259/nmji_420_2024
Alzarooni, H., Zeb, F., & Papandreou, D. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1974621
Silva, M. S., Ribeiro, P., Silva, J. C. D., Carvalho, R., Correia, A. S., Pinto, D., & Sousa, A. R. (2026) · Cureus · doi:10.7759/cureus.118769
Metadata
- Authors
- Li, X., Liu, Y., Zheng, Y., Wang, P., & Zhang, Y.
- Affiliations
- Peking University (CN)
- Corresponding author
- Zhang, Yumei
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2018-03-19
- Volume
- 10
- Issue
- 3
- Pages
- 375
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC5872793
- OpenAlex
- W2789558207
- Cited by
- 266
- References
- 50
- Citations by year
- 2026: 16 · 2025: 25 · 2024: 44 · 2023: 48 · 2022: 51 · 2021: 35 · 2020: 18 · 2019: 23 · 2018: 6
- FWCI
- 3.03
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (81573429, 2017YFD0400602)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- vitamin D supplementation, type 2 diabetes, glycemic control, insulin resistance, HOMA-IR, serum 25-hydroxyvitamin D, fasting blood glucose, HbA1c, fasting insulin, vitamin D deficiency, dose and duration effects, obesity, Middle Eastern populations
- MeSH terms
- Adult, Aged, Blood Glucose, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Insulin Resistance, Male, Middle Aged, Vitamin D, Vitamin D Deficiency, Biomarkers, Treatment Outcome, Dietary Supplements
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.